HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Magdalena Milczarek Selected Research

24a-homo-1,15-dihydroxyergocalciferol

10/2008Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Magdalena Milczarek Research Topics

Disease

21Neoplasms (Cancer)
01/2022 - 01/2007
10Breast Neoplasms (Breast Cancer)
11/2020 - 09/2007
6Colonic Neoplasms (Colon Cancer)
01/2022 - 02/2013
5Neoplasm Metastasis (Metastasis)
11/2020 - 06/2013
3Lung Neoplasms (Lung Cancer)
01/2022 - 09/2007
3Leukemia
07/2019 - 10/2008
2Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 01/2019
1Vitamin D Deficiency
11/2020
1Lymphoma (Lymphomas)
09/2019
1B-Cell Lymphoma (Lymphoma, B Cell)
09/2019
1Prostatic Neoplasms (Prostate Cancer)
07/2019
1Carcinoma (Carcinomatosis)
01/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2018
1Osteoporosis
01/2018
1Hepatitis B
01/2014
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2007

Drug/Important Bio-Agent (IBA)

8Vitamin DFDA LinkGeneric
11/2020 - 01/2007
7Calcitriol (Calcijex)FDA LinkGeneric
11/2020 - 01/2007
61 alpha,24-dihydroxyvitamin D3 (Tacalcitol)IBA
01/2019 - 10/2008
5calcipotriene (calcipotriol)FDA LinkGeneric
08/2014 - 09/2007
4Cisplatin (Platino)FDA LinkGeneric
11/2020 - 09/2007
31,25-dihydroxyergocalciferolIBA
01/2020 - 10/2008
3Fluorouracil (Carac)FDA LinkGeneric
01/2019 - 06/2013
3Cytostatic AgentsIBA
02/2018 - 01/2007
2IntegrinsIBA
10/2020 - 10/2008
2Doxorubicin (Adriamycin)FDA LinkGeneric
07/2019 - 09/2007
2VaccinesIBA
01/2019 - 01/2014
2Fibrinogen (Factor I)FDA Link
01/2019 - 11/2018
21- hydroxy- 2- oxo- 3,3- bis(2- aminoethyl)- 1- triazeneIBA
01/2019 - 11/2018
2xanthohumolIBA
11/2018 - 04/2013
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2018 - 01/2018
2Calcitriol Receptors (Calcitriol Receptor)IBA
08/2014 - 02/2013
2Therapeutic UsesIBA
08/2014 - 09/2007
2Biological ProductsIBA
10/2013 - 06/2013
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2008 - 09/2007
1C 1305IBA
01/2022
1Paclitaxel (Taxol)FDA LinkGeneric
01/2022
1Cholecalciferol (Vitamin D3)FDA Link
11/2020
1IsomerasesIBA
10/2020
1Proteins (Proteins, Gene)FDA Link
10/2020
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2020
1Collagen Type I (Type I Collagen)IBA
10/2020
1Caspase 3 (Caspase-3)IBA
10/2020
1Fibronectins (Fibronectin)IBA
10/2020
1IridiumIBA
08/2020
1DNA (Deoxyribonucleic Acid)IBA
08/2020
1AntigensIBA
09/2019
1Biomarkers (Surrogate Marker)IBA
09/2019
1Methotrexate (Mexate)FDA LinkGeneric
09/2019
1Endothelin-1 (Endothelin 1)IBA
01/2019
1sodium boranocarbonateIBA
01/2019
1Pharmaceutical PreparationsIBA
01/2019
1InterleukinsIBA
01/2019
1Thymidylate SynthaseIBA
01/2019
1Interleukin-12 (IL 12)IBA
01/2019
1SelectinsIBA
01/2019
1Small Interfering RNA (siRNA)IBA
01/2019
1isoxanthohumolIBA
11/2018
16-prenylnaringeninIBA
11/2018
1ChalconesIBA
11/2018
1FlavonoidsIBA
11/2018
18-prenylnaringeninIBA
11/2018
1Cadherins (E-Cadherin)IBA
11/2018
1Clopidogrel (Plavix)FDA Link
11/2018
1Tyrosine Kinase InhibitorsIBA
02/2018
1Sunitinib (Sutent)FDA Link
02/2018
1Imatinib Mesylate (Gleevec)FDA Link
02/2018
1hydroxide ionIBA
02/2018
1Docetaxel (Taxotere)FDA Link
02/2018
1OsteopontinIBA
01/2018
1CollagenIBA
01/2018
1Surface Antigens (Surface Antigen)IBA
01/2014
1Epirubicin (Ellence)FDA LinkGeneric
01/2014
1Edetic Acid (EDTA)FDA Link
01/2014
1Capecitabine (Xeloda)FDA Link
06/2013
11,1-diphenyl-2-picrylhydrazylIBA
04/2013
1Mitogen-Activated Protein Kinase 3IBA
02/2013
1Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2013
1Irinotecan (Camptosar)FDA LinkGeneric
02/2013
124a-homo-1,15-dihydroxyergocalciferolIBA
10/2008
1Cell Surface ReceptorsIBA
10/2008
1Integrin alphaVbeta3IBA
10/2008

Therapy/Procedure

11Therapeutics
01/2022 - 09/2007
1Transplantation
11/2020
1Treatment Delay
01/2018
1Aftercare (After-Treatment)
08/2014